BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

PTC Therapeutics, Inc. 

100 Corporate Court

South Plainfield  New Jersey  07080-2449  U.S.A.
Phone: 908-222-7000 Fax: 908-222-7231


SEARCH JOBS

View Clinical Trials from BioPharm Insight




Segment
Drug Discovery





 Company News
PTC Therapeutics (PTCT) Reports Fourth Quarter And 2014 Full Year Financial Results And Provides Corporate Update 2/27/2015 9:38:57 AM
PTC Therapeutics, Inc. (PTCT) To Participate At Upcoming March Investor Conferences 2/16/2015 11:43:43 AM
PTC Therapeutics, Inc. (PTCT) To Host Conference Call To Discuss Fourth Quarter And Year End 2014 Financial Results 2/16/2015 11:23:36 AM
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 2/9/2015 7:46:46 AM
PTC Therapeutics, Inc. (PTCT) To Participate At Upcoming Investor Conferences 2/6/2015 7:45:46 AM
PTC Therapeutics, Inc. (PTCT) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/7/2015 8:58:07 AM
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 1/5/2015 8:13:20 AM
PTC Therapeutics, Inc. (PTCT) Begins Rolling NDA Submission To The FDA For Translarna To Treat Duchenne Muscular Dystrophy 12/23/2014 7:57:36 AM
PTC Therapeutics, Inc. (PTCT) Release: Translarna Granted Orphan Drug Designation In The U.S. And Europe For The Treatment Of Mucopolysaccharidosis I 12/19/2014 8:03:40 AM
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 12/18/2014 7:44:02 AM
12345678910...